We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Catalent Completes Expansion of its Advanced Dose Form Facility in Italy
News

Catalent Completes Expansion of its Advanced Dose Form Facility in Italy

Catalent Completes Expansion of its Advanced Dose Form Facility in Italy
News

Catalent Completes Expansion of its Advanced Dose Form Facility in Italy

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Catalent Completes Expansion of its Advanced Dose Form Facility in Italy"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Catalent Pharma Solutions has announced the completion of the on-going expansion of its facility in Aprilia, Italy.

This expansion offers customers a complete ‘turnkey’ service from product conceptualization to formulation, development, production and packaging for prescription and over-the-counter products.

It also further enhances Catalent’s comprehensive European quality and analytical capabilities that include a wide range of services such as market registration, analytical testing and market release by Qualified Persons.

Catalent has proven expertise in overcoming solubility, stability and bioavailability challenges for a wide range of liquid and semi-solid formulations.

Innovative products manufactured at its Aprilia site include Vegicaps® capsules which enable better treatments through enhanced bioavailability for a wide range of APIs requiring higher temperature processing.

“Expanding our drug delivery capabilities and expertise reinforces Catalent Aprilia’s position as a leading integrated development and delivery facility in Southern Europe,” said Stefano Arena, General Manager of the site.

This expansion was successfully inspected by the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA) last month, and is the latest in a number of expansions that Catalent has made across Europe, South America and the United States.

Advertisement